6505-01-243-7919 ( INSULATARD NPH HUMAN , NDC50445-0222-01 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-243-7919 | 6505 | 012437919 | INSULIN HUMAN ISOPHANE SUSPENSIO | 3881 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| FEAT | SPECIAL FEATURES | DERIVED BY ENZYMATIC MODIFICATION OF PORK INSULIN |
| CRMW | RAW MATERIAL SOURCE | PORK PANCREAS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 100.000 UNITS INSULIN, ISOPHANE PER MILLILITER |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 10.000 MILLILITERS |
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| INSULATARD NPH HUMAN | 60554 | A | 1 | 5 | 6 | 54 | |
| NDC50445-0222-01 | 60554 | A | 2 | 3 | 6 | 54 |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| INSULATARD NPH HUMAN | 60554 | NOVO NORDISK INC. | A | A |
| NDC50445-0222-01 | 60554 | NOVO NORDISK INC. | A | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| U | X | A | 1 | 10/31/1 | P | 3004310000 | 3881 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 10 ML |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | U | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | VI | M | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|